Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Delcath Systems, Inc.(DCTH) | 3,300,389 | 3,300,389 | 0 | $41.55M | $52.71M | 17.04% | +$11.16M |
| Verastem, Inc.(VSTM) | 3,986,509 | 4,236,509 | +250,000 | $15.23M | $34.10M | 11.03% | +$18.88M |
| Fennec Pharmaceuticals Inc.(FENC) | 3,188,001 | 3,188,001 | 0 | $34.27M | $33.95M | 10.98% | -$318.8K |
| Xeris Biopharma Holdings Inc | 2,908,981 | 2,582,647 | -326,334 | $23.04M | $24.69M | 7.98% | +$1.65M |
| Helus Pharma Inc(HELP) | 1,956,814 | 1,387,969 | -568,845 | $12.93M | $17.06M | 5.52% | +$4.12M |
| Savara Inc.(SVRA) | 3,178,121 | 3,178,121 | 0 | $19.58M | $16.40M | 5.30% | -$3.18M |
| Replimune Group, Inc.(REPL) | 0 | 1,000,000 | +1,000,000 | $0 | $13.24M | 4.28% | +$13.24M |
| Vor Biopharma Inc.(VOR) | 648,600 | 609,199 | -39,401 | $11.94M | $11.62M | 3.76% | -$317.2K |
| MediWound Ltd.SHS NEW(MDWD) | 749,054 | 749,054 | 0 | $11.01M | $10.31M | 3.34% | -$696.6K |
| X4 Pharmaceuticals, Inc.(XFOR) | 3,214,766 | 3,214,766 | 0 | $15.01M | $9.32M | 3.01% | -$5.69M |
| Aquestive Therapeutics Inc | 250,000 | 2,000,000 | +1,750,000 | $1.04M | $9.26M | 2.99% | +$8.22M |
| Vaxcyte, Inc.(PCVX) | 200,000 | 149,361 | -50,639 | $11.63M | $8.50M | 2.75% | -$3.13M |
| Protara Therapeutics, Inc.(TARA) | 0 | 2,400,000 | +2,400,000 | $0 | $7.32M | 2.37% | +$7.32M |
| Myomo, Inc.(MYO) | 3,637,886 | 3,917,886 | +280,000 | $3.78M | $6.11M | 1.98% | +$2.33M |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 721,504 | 721,504 | 0 | $7.22M | $6.01M | 1.94% | -$1.20M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 0 | 2,200,000 | +2,200,000 | $0 | $5.79M | 1.87% | +$5.79M |
| PepGen Inc.(PEPG) | 350,000 | 2,000,000 | +1,650,000 | $630.0K | $4.84M | 1.57% | +$4.21M |
| Profound Medical Corp.(PROF) | 828,118 | 828,118 | 0 | $5.51M | $4.80M | 1.55% | -$703.9K |
| Talphera, Inc.(TLPH) | 5,169,501 | 4,134,144 | -1,035,357 | $5.32M | $4.80M | 1.55% | -$529.0K |
| NeurAxis, Inc.(NRXS) | 508,055 | 548,123 | +40,068 | $2.97M | $4.04M | 1.31% | +$1.07M |
| Ovid Therapeutics Inc.(OVID) | 1,107,994 | 1,107,994 | 0 | $2.98M | $2.76M | 0.89% | -$221.6K |
| InspireMD, Inc.(NSPR) | 3,905,743 | 3,905,743 | 0 | $2.73M | $2.62M | 0.85% | -$117.6K |
| Acumen Pharmaceuticals, Inc.(ABOS) | 0 | 1,100,000 | +1,100,000 | $0 | $2.44M | 0.79% | +$2.44M |
| EyePoint, Inc.(EYPT) | 988,230 | 695,977 | -292,253 | $14.13M | $2.28M | 0.74% | -$11.86M |
| ABIVAX Société AnonymeADS(ABVX) | 20,869 | 20,869 | 0 | $2.78M | $2.07M | 0.67% | -$714.6K |
| Biofrontera Inc.(BFRI) | 1,275,609 | 1,789,288 | +513,679 | $1.21M | $1.93M | 0.62% | +$726.3K |
| Femasys Inc | 0 | 759,213 | +759,213 | $0 | $1.64M | 0.53% | +$1.64M |
| Atea Pharmaceuticals, Inc.(AVIR) | 1,070,550 | 280,061 | -790,489 | $4.98M | $1.46M | 0.47% | -$3.52M |
| CG Oncology, Inc.(CGON) | 0 | 20,000 | +20,000 | $0 | $1.42M | 0.46% | +$1.42M |
| Spruce Biosciences Inc | 20,000 | 26,517 | +6,517 | $1.08M | $1.29M | 0.42% | +$208.2K |
| Regentis Biomaterials Ltd.(RGNT) | 701,685 | 701,685 | 0 | $2.48M | $1.27M | 0.41% | -$1.21M |
| Kura Oncology, Inc.(KURA) | 100,000 | 100,000 | 0 | $1.10M | $1.07M | 0.35% | -$26.0K |
| Grace Therapeutics, Inc.(GRCE) | 0 | 476,190 | +476,190 | $0 | $1.02M | 0.33% | +$1.02M |
| PolyPid Ltd.(PYPD) | 389,455 | 177,011 | -212,444 | $1.98M | $932.8K | 0.30% | -$1.05M |
| OnKure Therapeutics, Inc.CL A(OKUR) | 150,000 | 67,506 | -82,494 | $684.0K | $184.0K | 0.06% | -$500.0K |
| Celldex Therapeutics, Inc.(CLDX) | 200,000 | 0 | -200,000 | $7.44M | $0 | — | -$7.44M |